je.st
news
The Wall Street Journal: NovoCure falls below reduced IPO price in market debut
2015-10-03 22:12:05| Biotech - Topix.net
Shares in oncology company NovoCure Ltd. fell sharply in their trading debut Friday, the latest example of investors' waning appetite for biotechnology shares and for initial public offerings. shares opened at $20.16, below their initial public offering price of $22.
Tags: price
street
market
journal
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||